Ann Dewitt, Flagship Ventures

Judge, 2010 Global Finals
LinkedIn

Ann joined Sanofi-Genzyme BioVentures in 2013 with a background in biotech partnering and early stage investment. Prior to SGBV, Ann was Senior Director, Corporate Development at Permeon Biologics and led a collaboration with a large pharmaceutical partner. Previously, Ann was a Senior Associate at Flagship Ventures, an early stage venture capital firm investing in healthcare companies with over $900 million under management and was a Board observer for several portfolio companies. While at Harvard, she was an entrepreneur-in-residence at Highland Capital Management and a founding team member of Novophage Therapeutics (now Sample6). Post-doctorate, she worked at 3M Company in corporate research and in business units, including 3M Pharmaceuticals, and was a Technical Circle of Excellence Award winner.

Ann is also on the Life Sciences Council of Springboard Enterprises, an organization dedicated to building high-growth technology-oriented companies led by women.

Ann holds a B.S. from the University of Illinois Urbana-Champaign, a Ph.D. from MIT in systems biology, and an M.B.A. from Harvard Business School.

2010-10-12T11:21:49+00:002010 Global Finals, Judge|